These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37236761)

  • 1. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease.
    Spite M; Fredman G
    Adv Pharmacol; 2023; 97():257-281. PubMed ID: 37236761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
    Serhan CN; Libreros S; Nshimiyimana R
    Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target.
    Zhao M; Zheng Z; Yin Z; Zhang J; Qin J; Wan J; Wang M
    Pharmacol Res; 2023 Sep; 195():106832. PubMed ID: 37364787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncovering the Power of GPR18 Signalling: How RvD2 and Other Ligands Could Have the Potential to Modulate and Resolve Inflammation in Various Health Disorders.
    Honkisz-Orzechowska E; Łażewska D; Baran G; Kieć-Kononowicz K
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.
    Díaz Del Campo LS; Rodrigues-Díez R; Salaices M; Briones AM; García-Redondo AB
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
    Motwani MP; Colas RA; George MJ; Flint JD; Dalli J; Richard-Loendt A; De Maeyer RP; Serhan CN; Gilroy DW
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specialized pro-resolving mediator network: an update on production and actions.
    Chiang N; Serhan CN
    Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The resolvin D2 - GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice.
    Bardin M; Pawelzik SC; Lagrange J; Mahdi A; Arnardottir H; Regnault V; Fève B; Lacolley P; Michel JB; Mercier N; Bäck M
    Biochem Pharmacol; 2022 Jul; 201():115075. PubMed ID: 35525326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives.
    Mastromarino M; Lacivita E; Colabufo NA; Leopoldo M
    Mini Rev Med Chem; 2020; 20(20):2090-2103. PubMed ID: 32682373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic Nanocarriers of Pro-Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis.
    Anghelache M; Voicu G; Deleanu M; Turtoi M; Safciuc F; Anton R; Boteanu D; Fenyo IM; Manduteanu I; Simionescu M; Calin M
    Adv Healthc Mater; 2024 Jan; 13(3):e2302238. PubMed ID: 37852632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
    Recchiuti A; Serhan CN
    Front Immunol; 2012; 3():298. PubMed ID: 23093949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
    Fredman G
    Front Pharmacol; 2019; 10():205. PubMed ID: 30899222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
    Kotlyarov S; Kotlyarova A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.
    Satish M; Agrawal DK
    Expert Rev Cardiovasc Ther; 2019 Mar; 17(3):177-184. PubMed ID: 30582389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease.
    Pirault J; Bäck M
    Front Pharmacol; 2018; 9():1273. PubMed ID: 30487747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-resolution therapeutics for cardiovascular diseases.
    Heinz J; Marinello M; Fredman G
    Prostaglandins Other Lipid Mediat; 2017 Sep; 132():12-16. PubMed ID: 28450270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.
    Chiurchiù V; Leuti A; Dalli J; Jacobsson A; Battistini L; Maccarrone M; Serhan CN
    Sci Transl Med; 2016 Aug; 8(353):353ra111. PubMed ID: 27559094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
    Serhan CN; de la Rosa X; Jouvene C
    J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.
    Salazar J; Pirela D; Nava M; Castro A; Angarita L; Parra H; Durán-Agüero S; Rojas-Gómez DM; Galbán N; Añez R; Chacín M; Diaz A; Villasmil N; De Sanctis JB; Bermúdez V
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.